• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    R1 RCM Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/22/24 4:51:02 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary
    Get the next $RCM alert in real time by email
    achi-20240522
    0001910851falseR1 RCM Inc. /DE00019108512024-05-222024-05-22

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    ________________________

    FORM 8-K
    ________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 22, 2024
    ____________
    R1 RCM Inc.
    (Exact Name of Registrant as Specified in Charter)  
     ____________
    Delaware001-4142887-4340782
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    433 W. Ascension Way84123
    Suite 200
    Murray
    Utah
    (Address of Principal Executive Offices)(Zip Code)
    Registrant’s telephone number, including area code: (312) 324-7820

    (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))     
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, par value $0.01 per shareRCM
    NASDAQ
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐        



    Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    On May 22, 2024, R1 RCM Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the adoption of the R1 RCM Inc. Fifth Amended and Restated 2010 Stock Incentive Plan (the “Fifth A&R Plan”), which amends and restates the R1 RCM Inc. Fourth Amended and Restated 2010 Stock Incentive Plan (the “Fourth A&R Plan”). The Fifth A&R Plan authorizes the issuance of an additional 9,300,000 shares of the Company’s common stock pursuant to stock options, awards of restricted stock, restricted stock units, performance awards, stock appreciation rights and other stock-based awards. The material terms of the Fifth A&R Plan are summarized on pages 9 through 16 of the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 12, 2024, the description of which is incorporated herein by reference.

    The description of the Fifth A&R Plan is qualified in its entirety by reference to the full text of the Fifth A&R Plan, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

    Item 5.07    Submission of Matters to a Vote of Security Holders

    At the Annual Meeting, there were present, in person or by proxy, 399,831,493 shares of the Company’s common stock representing at least a majority of the Company’s common stock issued, outstanding, and entitled to vote thereat, constituting a quorum for all matters presented at the Annual Meeting. At the Annual Meeting, the Company’s stockholders voted on the following proposals, with the following results:

    1. The following nominees were elected to the Company’s board of directors for terms ending at the 2025 annual meeting of stockholders:

    ForWithheldBroker Non-Votes
    Bradford Kyle Armbrester304,985,488 83,197,558 11,648,447 
    Clay Ashdown380,750,669 7,432,377 11,648,447 
    Agnes Bundy Scanlan385,990,656 2,192,390 11,648,447 
    Jeremy Delinsky380,899,391 7,283,655 11,648,447 
    David M. Dill380,690,669 7,492,377 11,648,447 
    Michael C. Feiner369,078,946 19,104,100 11,648,447 
    Joseph Flanagan304,862,821 83,320,225 11,648,447 
    John B. Henneman III371,951,672 16,231,374 11,648,447 
    Matthew Holt310,534,023 77,649,023 11,648,447 
    Neal Moszkowski301,827,786 86,355,260 11,648,447 
    Dominic Nakis373,401,598 14,781,448 11,648,447 
    Lee Rivas386,374,478 1,808,568 11,648,447 
    Ian Sacks367,059,840 21,123,206 11,648,447 
    Jill Smith375,330,427 12,852,619 11,648,447 
    Anthony J. Speranzo378,795,203 9,387,843 11,648,447 
    Anthony R. Tersigni379,404,921 8,778,125 11,648,447 
    Erik G. Wexler380,747,352 7,435,694 11,648,447 

    2. The Company’s stockholders approved the Fifth A&R Plan, including to increase the number of shares authorized for issuance under the Fourth A&R Plan by 9,300,000 shares:




    For:381,593,869 
    Against:6,480,114 
    Abstain:109,063 
    Broker Non-Votes:11,648,447 

    3. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers:

    For:369,033,231 
    Against:19,033,625 
    Abstain:116,190 
    Broker Non-Votes:11,648,447 

    4. The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024:

    For:369,043,103 
    Against:3,642,716 
    Abstain:145,674 


    Item 9.01    Financial Statements and Exhibits

    (d)Exhibit NumberDescription
    10.1
    R1 RCM Inc. Fifth Amended and Restated 2010 Stock Incentive Plan
    104Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    R1 RCM INC.
    Date: May 22, 2024
    By:       /s/ Jennifer Williams                                    
     Name:  Jennifer Williams
     Title:    Chief Financial Officer


    Get the next $RCM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RCM

    DatePrice TargetRatingAnalyst
    8/8/2024Overweight → Equal-Weight
    Morgan Stanley
    8/1/2024Overweight → Equal-Weight
    Stephens
    8/1/2024Outperform → Market Perform
    Leerink Partners
    8/1/2024Buy → Hold
    Jefferies
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    3/20/2024$16.00Neutral → Buy
    Citigroup
    2/26/2024$14.00Outperform
    Leerink Partners
    1/3/2024$14.00Overweight
    Barclays
    More analyst ratings

    $RCM
    SEC Filings

    View All

    SEC Form POSASR filed by R1 RCM Inc.

    POSASR - R1 RCM Inc. /DE (0001910851) (Filer)

    11/19/24 4:26:18 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by R1 RCM Inc.

    S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

    11/19/24 4:18:28 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by R1 RCM Inc.

    S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

    11/19/24 4:17:27 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    $RCM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TowerBrook and CD&R Complete Acquisition of R1 RCM

    MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w

    11/19/24 9:06:28 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Shift4 Payments Set to Join the S&P MidCap 400

    NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

    11/15/24 6:15:00 PM ET
    $FOUR
    $RCM
    $SPGI
    Real Estate
    Other Consumer Services
    Consumer Discretionary
    Finance: Consumer Services

    R1 RCM Reports Third Quarter 2024 Results

    MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

    11/5/24 7:00:00 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    $RCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $RCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)

    4 - R1 RCM Inc. /DE (0001910851) (Issuer)

    11/22/24 4:05:14 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)

    4 - R1 RCM Inc. /DE (0001910851) (Issuer)

    11/19/24 5:37:21 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)

    4 - R1 RCM Inc. /DE (0001910851) (Issuer)

    11/19/24 5:35:59 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    R1 RCM downgraded by Morgan Stanley

    Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight

    8/8/24 8:58:18 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    R1 RCM downgraded by Stephens

    Stephens downgraded R1 RCM from Overweight to Equal-Weight

    8/1/24 9:39:53 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    R1 RCM downgraded by Leerink Partners

    Leerink Partners downgraded R1 RCM from Outperform to Market Perform

    8/1/24 9:39:53 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    $RCM
    Financials

    Live finance-specific insights

    View All

    R1 RCM Reports Third Quarter 2024 Results

    MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

    11/5/24 7:00:00 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    R1 RCM Reports Second Quarter 2024 Results

    MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte

    8/7/24 7:00:00 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

    MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

    8/1/24 7:30:34 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    $RCM
    Leadership Updates

    Live Leadership Updates

    View All

    Shift4 Payments Set to Join the S&P MidCap 400

    NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

    11/15/24 6:15:00 PM ET
    $FOUR
    $RCM
    $SPGI
    Real Estate
    Other Consumer Services
    Consumer Discretionary
    Finance: Consumer Services

    James Hardie Industries Announces Global Leadership Appointment

    Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li

    8/16/23 9:50:00 PM ET
    $JHX
    $RCM
    Building Materials
    Industrials
    Other Consumer Services
    Consumer Discretionary

    R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

    MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian

    8/12/21 8:00:00 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    $RCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    11/22/24 4:06:56 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    11/19/24 4:36:38 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

    8/5/24 7:31:56 AM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary